ENZAPROST T DIN 02468697
Status: Marketed
Holder: CEVA ANIMAL HEALTH INC
Health Canada record
| Active ingredient(s) | DINOPROST (DINOPROST TROMETHAMINE) 5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous; Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 20-Aug-2018 |
|---|
| Current status date | 20-Aug-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Ceva Animal Health Inc — licence 102054, currently licensed, last inspection rating C (2024-07-31).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DINOPROST (DINOPROST TROMETHAMINE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00813605 | LUTALYSE | ZOETIS CANADA INC | Solution | DINOPROST (DINOPROST TROMETHAMINE) 5 MG | Marketed |
| 02460394 | LUTALYSE HC | ZOETIS CANADA INC | Solution | DINOPROST (DINOPROST TROMETHAMINE) 12.5 MG | Approved |
| 00318736 | PROSTIN F2 ALPHA | PFIZER CANADA ULC | Solution | DINOPROST (DINOPROST TROMETHAMINE) 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 20222 | 2018-01-03 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for ENZAPROST T
How to read a Canadian DIN record